HEPLISAV-B

Dynavax Technologies Corporation’s (DVAX) Hepatitis B Vaccine Wins FDA Approval

Dynavax Technologies Corporation (NASDAQ:DVAX) has won U.S.

Corey Williams — November 9, 2017, 5:12 PM EDT